Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-5751
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids ; volume:13 ; number:1 ; day:13 ; month:6 ; year:2014 ; pages:1-9 ; date:12.2014
Journal of negative results in biomedicine ; 13, Heft 1 (13.6.2014), 1-9, 12.2014
- Urheber
-
Lötvall, Jan
- Beteiligte Personen und Organisationen
-
Bateman, Eric D.
Busse, William W.
O’Byrne, Paul M.
Woodcock, Ashley
Toler, William T.
Jacques, Loretta
Goldfrad, Caroline
Bleecker, Eugene R.
SpringerLink (Online service)
- DOI
-
10.1186/1477-5751-13-9
- URN
-
urn:nbn:de:1111-201603254661
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lötvall, Jan
- Bateman, Eric D.
- Busse, William W.
- O’Byrne, Paul M.
- Woodcock, Ashley
- Toler, William T.
- Jacques, Loretta
- Goldfrad, Caroline
- Bleecker, Eugene R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
A self-rating scale for patient-perceived side effects of inhaled corticosteroids
Relative receptor affinity comparisons among inhaled/intranasal corticosteroids: perspectives on clinical relevance
Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
A self-rating scale for patient-perceived side effects of inhaled corticosteroids
Relative receptor affinity comparisons among inhaled/intranasal corticosteroids: perspectives on clinical relevance
Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
A self-rating scale for patient-perceived side effects of inhaled corticosteroids
Relative receptor affinity comparisons among inhaled/intranasal corticosteroids: perspectives on clinical relevance